30
Participants
Start Date
August 27, 2021
Primary Completion Date
June 5, 2024
Study Completion Date
June 5, 2026
Surgery
Participants having been evaluated as operable after receiving first-line treatment (first-line chemotherapy, targeted therapy, immunotherapy, chemotherapy combined with immunotherapy, etc.) will receive surgery.
Ruijin hospital, Shanghai JiaoTong University School of Medicine, Shanghai
Ruijin Hospital
OTHER